Earnings Summary

Hca Holdings, Inc.’s revenue jumped 10.28% since last year same period to $17492Mn in the Q2 2024. On a quarterly growth basis, Hca Holdings, Inc. has generated 0.88% jump in its revenue since last 3-months.

Hca Holdings, Inc.’s net profit jumped 22.46% since last year same period to $1461Mn in the Q2 2024. On a quarterly growth basis, Hca Holdings, Inc. has generated -8.17% fall in its net profits since last 3-months.

Hca Holdings, Inc.’s net profit margin jumped 11.05% since last year same period to 8.35% in the Q2 2024. On a quarterly growth basis, Hca Holdings, Inc. has generated -8.97% fall in its net profit margins since last 3-months.

Hca Holdings, Inc.’s price-to-earnings ratio after this Q2 2024 earnings stands at 19.51.

Hca Holdings, Inc.’s earning per share (EPS) estimates for the current quarter stand at 4.96 - a 2.27% jump from last quarter’s estimates.

Hca Holdings, Inc.’s earning per share (EPS) estimates for the current year stand at 4.96.

Hca Holdings, Inc.’s earning per share (EPS) jumped 28.9% since last year same period to 5.53 in the Q2 2024. This indicates that the Hca Holdings, Inc. has generated 28.9% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Hca Holdings, Inc.’s return on assets (ROA) stands at 0.11.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Hca Holdings, Inc.’s return on equity (ROE) stands at 0.74.

Hca Holdings, Inc. declared 0.66 dividend per share during the earnings announcement for Q2 2024.